A. Duquesne

2.1k total citations
39 papers, 1.0k citations indexed

About

A. Duquesne is a scholar working on Rheumatology, Hematology and Speech and Hearing. According to data from OpenAlex, A. Duquesne has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 11 papers in Hematology and 10 papers in Speech and Hearing. Recurrent topics in A. Duquesne's work include Autoimmune and Inflammatory Disorders Research (11 papers), Adolescent and Pediatric Healthcare (10 papers) and Inflammasome and immune disorders (8 papers). A. Duquesne is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (11 papers), Adolescent and Pediatric Healthcare (10 papers) and Inflammasome and immune disorders (8 papers). A. Duquesne collaborates with scholars based in France, United States and Switzerland. A. Duquesne's co-authors include Pierre Quartier, Rolando Cimaz, C Job-Deslandre, Pascal Pillet, Albert Faye, J. Wipff, Paul Landais, Damien Chaussabel, Xavier Bossuyt and Jean‐Marc Tréluyer and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and The Journal of Pediatrics.

In The Last Decade

A. Duquesne

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Duquesne France 12 447 394 366 315 249 39 1.0k
Nuray Aktay Ayaz Türkiye 17 274 0.6× 257 0.7× 350 1.0× 598 1.9× 371 1.5× 135 1.1k
Melissa L. Mannion United States 14 204 0.5× 274 0.7× 583 1.6× 191 0.6× 265 1.1× 30 963
Minako Tomiita Japan 16 224 0.5× 248 0.6× 606 1.7× 259 0.8× 299 1.2× 53 1.2k
Amra Adroviç Türkiye 23 373 0.8× 334 0.8× 542 1.5× 629 2.0× 493 2.0× 128 1.6k
Judyann C. Olson United States 17 543 1.2× 188 0.5× 760 2.1× 283 0.9× 541 2.2× 32 1.4k
Femke H. M. Prince Netherlands 14 412 0.9× 240 0.6× 784 2.1× 303 1.0× 289 1.2× 19 1.1k
I. Lemelle France 9 493 1.1× 379 1.0× 712 1.9× 289 0.9× 202 0.8× 31 1.2k
James Birmingham United States 10 224 0.5× 310 0.8× 388 1.1× 181 0.6× 211 0.8× 11 814
Richard K. Vehe United States 17 330 0.7× 235 0.6× 736 2.0× 213 0.7× 235 0.9× 34 1.2k
Karla Jones United States 12 221 0.5× 172 0.4× 429 1.2× 139 0.4× 205 0.8× 16 814

Countries citing papers authored by A. Duquesne

Since Specialization
Citations

This map shows the geographic impact of A. Duquesne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Duquesne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Duquesne more than expected).

Fields of papers citing papers by A. Duquesne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Duquesne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Duquesne. The network helps show where A. Duquesne may publish in the future.

Co-authorship network of co-authors of A. Duquesne

This figure shows the co-authorship network connecting the top 25 collaborators of A. Duquesne. A scholar is included among the top collaborators of A. Duquesne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Duquesne. A. Duquesne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duquesne, A., et al.. (2024). JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. Journal of Autoimmunity. 147. 103248–103248. 4 indexed citations
2.
Magnotti, Flora, Amandine Martin, Michel R. Popoff, et al.. (2023). Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation. Cell Death and Disease. 14(3). 213–213. 9 indexed citations
3.
Sève, P., et al.. (2023). Uveitis in children: Epidemiological, clinical and prognostic characteristics. Journal Français d Ophtalmologie. 46(2). 163–172. 3 indexed citations
4.
Guillem, Philippe, Dillon Mintoff, Elie Cogan, et al.. (2022). Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa – A New Syndromic Form of HS? A Report of Two Cases. Frontiers in Immunology. 13. 883811–883811. 7 indexed citations
5.
Lohse, Anne, I. Lemelle, Pascal Pillet, et al.. (2021). Therapeutic alliance is associated to treatment adherence in children with juvenile idiopathic arthritis. Joint Bone Spine. 88(4). 105151–105151. 3 indexed citations
6.
Georgin‐Lavialle, Sophie, Véronique Hentgen, Marie‐Elise Truchetet, et al.. (2021). La transition de la pédiatrie à l’âge adulte : recommandations de prise en charge de la filière des maladies auto-immunes et auto-inflammatoires rares FAI2R. La Revue de Médecine Interne. 42(9). 633–638. 4 indexed citations
7.
Bélot, Alexandre, A. Duquesne, Bérengère Aubry‐Rozier, et al.. (2020). Comparison of paediatric and adult classification criteria in juvenile idiopathic arthritis during the transition from paediatric to adult care. Joint Bone Spine. 88(1). 105047–105047. 7 indexed citations
8.
Meinzer, Ulrich, Hélène See, Brigitte Bader‐Meunier, et al.. (2020). Clinical Characteristics of Acne Fulminans Associated With Chronic Nonbacterial Osteomyelitis in Pediatric Patients. The Journal of Rheumatology. 47(12). 1793–1799. 8 indexed citations
9.
Magnotti, Flora, Sophie Georgin‐Lavialle, Fatima Abbas, et al.. (2020). Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor. Annals of the Rheumatic Diseases. 80(1). 128–132. 13 indexed citations
10.
Pereira, Bruno, et al.. (2017). MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance. Clinical Rheumatology. 36(6). 1281–1288. 9 indexed citations
11.
Duquesne, A., et al.. (2016). Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children. RMD Open. 2(2). e000271–e000271. 9 indexed citations
12.
Stagnara, J., et al.. (2010). Information et éducation des familles des enfants en situation d’urgence : objectifs des messages de santé. Archives de Pédiatrie. 17(6). 850–851. 1 indexed citations
13.
Stagnara, J., et al.. (2010). Information et éducation des familles des enfants en situation d’urgence : suivi d’intervention. Archives de Pédiatrie. 17(6). 856–857.
14.
Quartier, Pierre, Florence Allantaz, Rolando Cimaz, et al.. (2010). A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Annals of the Rheumatic Diseases. 70(5). 747–754. 381 indexed citations
15.
Dagher, Rawane, A. Duquesne, Pierre Quartier, et al.. (2010). Mycophenolate mofetil in juvenile dermatomyositis: a case series. Rheumatology International. 32(3). 711–716. 31 indexed citations
16.
17.
Bélot, Alexandre, A. Duquesne, C Job-Deslandre, et al.. (2009). Pediatric-Onset Relapsing Polychondritis: Case Series and Systematic Review. The Journal of Pediatrics. 156(3). 484–489. 41 indexed citations
18.
Bacchetta, Justine, Bruno Ranchin, Anne Brunet, et al.. (2009). Autoimmune hypoparathyroidism in a 12-year-old girl with McKusick cartilage hair hypoplasia. Pediatric Nephrology. 24(12). 2449–2453. 13 indexed citations
19.
Cimaz, Rolando & A. Duquesne. (2006). Le lupus néonatal. Archives de Pédiatrie. 13(5). 473–478. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuray Aktay Ayaz Breakdown of academic impact, for papers by Melissa L. Mannion Breakdown of academic impact, for papers by Minako Tomiita Breakdown of academic impact, for papers by Amra Adroviç Breakdown of academic impact, for papers by Judyann C. Olson Breakdown of academic impact, for papers by Femke H. M. Prince Breakdown of academic impact, for papers by I. Lemelle Breakdown of academic impact, for papers by James Birmingham Breakdown of academic impact, for papers by Richard K. Vehe Breakdown of academic impact, for papers by Karla Jones
Rankless by CCL
2026